These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24938130)

  • 21. Free Fatty Acid Receptor 4 (GPR120) Stimulates Bone Formation and Suppresses Bone Resorption in the Presence of Elevated n-3 Fatty Acid Levels.
    Ahn SH; Park SY; Baek JE; Lee SY; Baek WY; Lee SY; Lee YS; Yoo HJ; Kim H; Lee SH; Im DS; Lee SK; Kim BJ; Koh JM
    Endocrinology; 2016 Jul; 157(7):2621-35. PubMed ID: 27145004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strain-dependent variations in the response of cancellous bone to ovariectomy in mice.
    Iwaniec UT; Yuan D; Power RA; Wronski TJ
    J Bone Miner Res; 2006 Jul; 21(7):1068-74. PubMed ID: 16813527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deletion of histone deacetylase 7 in osteoclasts decreases bone mass in mice by interactions with MITF.
    Stemig M; Astelford K; Emery A; Cho JJ; Allen B; Huang TH; Gopalakrishnan R; Mansky KC; Jensen ED
    PLoS One; 2015; 10(4):e0123843. PubMed ID: 25875108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex-specific differences in direct osteoclastic
    Deosthale P; Hong JM; Essex AL; Rodriguez W; Tariq D; Sidhu H; Marcial A; Bruzzaniti A; Plotkin LI
    Bone Rep; 2022 Jun; 16():101164. PubMed ID: 35028339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of bone mass and osteoclast function depend on the F-actin modulator SWAP-70.
    Garbe AI; Roscher A; Schüler C; Lutter AH; Glösmann M; Bernhardt R; Chopin M; Hempel U; Hofbauer LC; Rammelt S; Egerbacher M; Erben RG; Jessberger R
    J Bone Miner Res; 2012 Oct; 27(10):2085-96. PubMed ID: 22648978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dok-1 and Dok-2 deficiency induces osteopenia via activation of osteoclasts.
    Kawamata A; Inoue A; Miyajima D; Hemmi H; Mashima R; Hayata T; Ezura Y; Amagasa T; Yamanashi Y; Noda M
    J Cell Physiol; 2011 Dec; 226(12):3087-93. PubMed ID: 21732353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro re-expression of the aryl hydrocarbon receptor (Ahr) in cultured Ahr-deficient mouse antral follicles partially restores the phenotype to that of cultured wild-type mouse follicles.
    Ziv-Gal A; Gao L; Karman BN; Flaws JA
    Toxicol In Vitro; 2015 Mar; 29(2):329-36. PubMed ID: 25500125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the aryl hydrocarbon receptor in the development of control and 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed male mice.
    Lin TM; Ko K; Moore RW; Buchanan DL; Cooke PS; Peterson RE
    J Toxicol Environ Health A; 2001 Oct; 64(4):327-42. PubMed ID: 11693491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Environmental toxicants may modulate osteoblast differentiation by a mechanism involving the aryl hydrocarbon receptor.
    Ryan EP; Holz JD; Mulcahey M; Sheu TJ; Gasiewicz TA; Puzas JE
    J Bone Miner Res; 2007 Oct; 22(10):1571-80. PubMed ID: 17576166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation.
    Zaiss MM; Sarter K; Hess A; Engelke K; Böhm C; Nimmerjahn F; Voll R; Schett G; David JP
    Arthritis Rheum; 2010 Aug; 62(8):2328-38. PubMed ID: 20506516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss.
    Ding KH; Wang ZZ; Hamrick MW; Deng ZB; Zhou L; Kang B; Yan SL; She JX; Stern DM; Isales CM; Mi QS
    Biochem Biophys Res Commun; 2006 Feb; 340(4):1091-7. PubMed ID: 16403440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.
    Idris AI; Landao-Bassonga E; Ralston SH
    Bone; 2010 Apr; 46(4):1089-99. PubMed ID: 20096813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of NF-κB1 prevents bone loss caused by mechanical unloading.
    Nakamura H; Aoki K; Masuda W; Alles N; Nagano K; Fukushima H; Osawa K; Yasuda H; Nakamura I; Mikuni-Takagaki Y; Ohya K; Maki K; Jimi E
    J Bone Miner Res; 2013 Jun; 28(6):1457-67. PubMed ID: 23322687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The aryl hydrocarbon receptor suppresses osteoblast proliferation and differentiation through the activation of the ERK signaling pathway.
    Yu H; Du Y; Zhang X; Sun Y; Li S; Dou Y; Li Z; Yuan H; Zhao W
    Toxicol Appl Pharmacol; 2014 Nov; 280(3):502-10. PubMed ID: 25194622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A chimeric aryl hydrocarbon receptor knockout mouse model indicates that aryl hydrocarbon receptor activation in hematopoietic cells contributes to the hepatic lesions induced by 2,3,7, 8-tetrachlorodibenzo-p-dioxin.
    Thurmond TS; Silverstone AE; Baggs RB; Quimby FW; Staples JE; Gasiewicz TA
    Toxicol Appl Pharmacol; 1999 Jul; 158(1):33-40. PubMed ID: 10387930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine A(1) receptors regulate bone resorption in mice: adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice.
    Kara FM; Doty SB; Boskey A; Goldring S; Zaidi M; Fredholm BB; Cronstein BN
    Arthritis Rheum; 2010 Feb; 62(2):534-41. PubMed ID: 20112380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RARγ is a negative regulator of osteoclastogenesis.
    Green AC; Poulton IJ; Vrahnas C; Häusler KD; Walkley CR; Wu JY; Martin TJ; Gillespie MT; Chandraratna RA; Quinn JM; Sims NA; Purton LE
    J Steroid Biochem Mol Biol; 2015 Jun; 150():46-53. PubMed ID: 25800721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-1 plays an important role in the bone metabolism under physiological conditions.
    Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
    Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TDAG8 activation inhibits osteoclastic bone resorption.
    Hikiji H; Endo D; Horie K; Harayama T; Akahoshi N; Igarashi H; Kihara Y; Yanagida K; Takeda J; Koji T; Shimizu T; Ishii S
    FASEB J; 2014 Feb; 28(2):871-9. PubMed ID: 24221084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of metastasin S100A4 is essential for bone resorption and regulates osteoclast function.
    Erlandsson MC; Svensson MD; Jonsson IM; Bian L; Ambartsumian N; Andersson S; Peng Z; Vääräniemi J; Ohlsson C; Andersson KME; Bokarewa MI
    Biochim Biophys Acta; 2013 Dec; 1833(12):2653-2663. PubMed ID: 23830916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.